1.
PDF
Yazdanifar_uncc_0694D_12224
CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL IMMUNOTHERAPY FOR MUCIN 1 (MUC1)-POSITIVE PANCREATIC DUCTAL ADENOCARCINOMA
Yazdanifar, Mahboubeh
Chimeric antigen receptor engineered (CAR) T cells have shown remarkable success in the treatment of hematologic cancers. However, this efficacy has yet to translate to t[...]
2019 | doctoral dissertations |
Detailed record - Similar records